Highlights from the 39th Society for Immunotherapy of Cancer Annual Meeting

The 39th Society for Immunotherapy of Cancer (SITC) Annual Meeting was held from November 6–10, 2024, at the George R. Brown Convention Center in Houston, Texas.

This milestone event brought together thousands of cancer immunotherapy experts from around the world to share the latest advancements, research findings, and clinical innovations. As one of the premier gatherings in the field, SITC 2024 provided a dynamic forum for discussion, education, and collaboration.

The Society for Immunotherapy of Cancer (SITC) is a globally recognized leader in advancing cancer immunotherapy. Founded in 1984, SITC brings together researchers, clinicians, and other healthcare professionals dedicated to the discovery and application of innovative immune-based therapies for cancer. As a member-driven society, SITC provides a dynamic forum for the exchange of knowledge, facilitates the translation of cutting-edge research into clinical practice, and supports the development of the next generation of cancer immunotherapy.

SITC:

“Congratulations to the 2024 inductees of the SITC Fellows of the Academy of Immo-Oncology (FAIO). Dr. Jedd Wolchok, Dr. Thomas Gajewski, Dr. Antoni Ribas, Dr. Glenn Dranoff, Dr. Ira Mellman and Dr. Laurence Zitvogel.”

Patrick Hwu:

“Congratulations to the SITC 2024 Class of Fellows, who were formally inducted into the Academy of Immuno-Oncology tonight!

• Glenn Dranoff
• Tom Gajewski
• Ira Mellman
• Antoni Ribas
• Jedd Wolchok
• Laurence Zitvogel.”

Bernard A Fox:

“The Amazing Prof Carlo Bifulco explains why Al wins out over humans in evaluating pathology sections which contain 100x more info than a whole body CAT Scan.”

Jessica Roeland:

“Heading back from an inspiring SITC2024!

Scott Engels presented our latest work using spatial transcriptomics to unravel the cellular communities at the basis of colorectal cancer onset. Loved the talks, early career events, and was great catching up with old friends!”

Mehdi Chaib:

“Honored and grateful to share our story on how perivascular TAMs promote resistance to immunotherapy from the Allison lab, and to receive the SITC2024 young investigator travel award. Great science and great people!”

Alessia Cortellini:
“Huge congratulations to Arielle Elkrief for her research award at SITC2024. Can’t imagine someone more deserving!”

Ty Miller:

“I’ll say it again, the best part of SITC 2024 is the people.

Praj Rajappa, Michelle Williams, Sneha Ramakrishn, Mara De Martino and friends.
Thanks for hosting Akoya Biosciences!”

Patrick Hwu:

“While at SITC24, Roger Li, MD joined me to discuss his study evaluating the use of combination oncolytic virotherapy and immune checkpoint inhibitor nivolumab to treat muscle-invasive Bladder Cancer. Check out our video below and read more about his work here.”

Christian Capitini:

“Superstar Pablo Martinez shows how BiTEs can have efficacy in solid tumors tarlatamab is the first BiTE approved for solid tumors and targets DLL3 x CD3 in lung cancer Has a prolonged half life compared to blinatumomab.”

Arun Kumar Arunachalam:

“Beautiful slides at SITC2024 by Dr Bifulco. Machine learning and digital pathology seem like the way forward for morphology. Has anyone tried Path Chat?”

Michelle Williams:

“24 has been a blast including presenting on my favorite topic, immunosuppressive myeloid cells! Thanks to the organizers for the opportunity Tullia Bruno and Eric Smith, and Lyndsey Sandra for the photography.”

David S. Hong:

“Nothing better as a mentor to see one of your mentees presenting at a major meeting SITC2024! Congrats Dr Derrick Tao!”

Nour Shobani:

“Honored to have given a talk at SITC2024 in Houston, sharing our latest on safe, effective CAR T cell therapies for prostate cancer. Grateful for the Muriel Joan Drew Hege Fund Award and the support of my mentors Carl June, Kristen Hege and Bruce Levine.”

Allison Betof Warner:

“Great ASPirE immunotherapy toxicity meeting at SITC2024 led by Pauline Funchain and Kerry Reynolds. I’m loving the flashbacks to MGH IM Residents with a chief resident chalk talk by Kerry!”

Wungki Park:

“Congrats Benoit JC Rousseau for Steven Rosenberg Award. How amazing~!! Meeting friends and alumni is always the highlight at conferences SITC 2024.”

Jon Salazar:

“Such a great time learning from and partying with the world’s most talented immunologists! I can’t wait until next year! Such a great time learning from and partying with the world’s most talented immunologists! I can’t wait until next year!”

R. Ryan Bell:

“Delighted to be at SITC Annual Meeting with my colleagues from Chiles Research Institute. Congrats to Bernard A Fox on his Lifetime Achievement Award and to our team, which is presenting 20 abstracts highlighting advances in immuno-oncology at providence.”

Katy Backermann:

“Prof Doug Johnson is the epitome of a physician-scientist! Teaching us today about the evolution of biomarkers in immunotherapy. Inspiring!”

Fabiola Osorio:

“Incredibly grateful to the society for immunotherapy of cancer SITC2024 meeting for inviting me to present our data in the Latinoamerican immuno-oncology simposium. A fantastic opportunity to share our work.”

Rebecca Lim:

“Kicking off SITC2024 with a pre-conference TIL symposium. The first session was a wonderful summary of the history of TIL discovery and development from the FIH trial in 1988 and the first marketing approval this year.”

Mohamed Derbala:

“Very happy to meet Dr. Patrick Hwu and Dr. Aung Naing at SITC2024 in Houston, TX, and get new insights on the latest trends in cancer immunotherapy and the gaps in knowledge that needs to be addressed.”

More posts featuring SITC on OncoDaily.

Bernard Fox received SITC lifetime achievement award